Mortality related to acute kidney injury is high and can exceed 50% with medications implicated in many cases. Despite the concurrent use of diuretics, angiotensin converting enzyme (ACE) inhibitors/angiotensin II receptor blockers (ARBs) with NSAIDs (‘triple whammy’) is commonly cited as a risk factor for acute kidney injury, there is limited published research.
|Number of pages||2|
|Journal||Journal of Pharmacy Practice and Research|
|Publication status||Published - 2013|